Search

everythinglearnresearchcommunity

for

Search:↓

Ovalbumin–aluminum sensitization causes increased pain sensitivity and nerve changes in mice.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Blocking interferon-gamma might help treat various autoimmune diseases.

Enhancing Tregs can protect against alopecia areata.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

Next-generation Treg therapies could help achieve lasting immune tolerance in type 1 diabetes.

Non-myeloablative stem cell transplants are a promising, less toxic option for older or weaker patients, with fewer side effects and good outcomes.

Targeted immunological therapies offer safer and more effective treatments for skin conditions like eczema and psoriasis.

Targeting thyroid hormone receptor α in liver cells may help treat liver fibrosis.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

The LTF gene may help predict and manage nonspecific orbital inflammation.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

TNF-alpha inhibitors can cause various immune-related skin issues.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Low-dose radiation and certain drugs can inhibit keloid growth, revealing potential treatment targets.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Immunosuppression therapy with methylprednisolone effectively treats childhood alopecia areata.

Blocking certain proteins on immune cells may help treat alopecia areata.

Enhancing immune response can improve cancer treatment effectiveness.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.